IBRX ImmunityBio, Inc.
$6.02
ImmunityBio, Inc. (IBRX) Earnings News
Earnings press releases, previews and reviews for ImmunityBio, Inc. (IBRX), newest first.
Monday
November 9, 2026
7:30 AM ET
ImmunityBio Reports Label Expansion and Additional Global Approval with Q3 2026 Net Product Revenue of $48.7 Million, Up 53% Year-Over-Year and First Nine Months U.S. Revenue Up 92% to $143.6 Million
Tuesday
August 4, 2026
7:30 AM ET
ImmunityBio Reports Record Q2 2026 Net Product Revenue of $50.7 Million, Up 92% Year-Over-Year; First-Half Revenue Up 121% to $94.8 Million